Oral Poliovirus Vaccine: History of Its Development and Use and Current Challenge to Eliminate Poliomyelitis from the World
Abstract
Oral poliovirus vaccine (OPV) is like no other live virus vaccine used in humans: vaccine strains multiply extensively in the intestinal tract, are widely disseminated in the family and community, and immunize a large proportion of the unvaccinated population. During the search for optimal strains for vaccine use, motor neurons in the spinal cord of chimpanzees (and by extrapolation those of humans) were found to be much more resistant to polioviruses than those of monkeys; the reverse was true for the alimentary tract. Various biologic properties of polioviruses also varied quantitatively over a wide spectrum and were genetically distinct. The phenomenon of somewhat increased neurovirulence for monkeys, but not for chimpanzees, encountered in excreted virus was extensively studied in families, in children's homes, and finally among hundreds of thousands of susceptible children and adults in areas where only 50% of the susceptible population received OPV; these studies did not reveal evidence of danger. During the past 20 years approximately 5 million cases of paralytic poliomyelitis were probably prevented by OPV in predominantly temperate-climate countries inhabited by approximately 2 billion people. OPV has also been used less extensively and not optimally in many tropical and subtropical countries, where paralytic poliomyelitis is now known to be an important public health problem, with reduction in numbers of cases but not elimination of the disease except in some countries with better health services. Experience in Cuba during the past 21 years, in Brazil during the past 5 years, and in the Dominican Republic during the past 2 years has shown that the strategy of annual short-term vaccination of all children in the most susceptible age groups can rapidly eliminate the disease from tropical and subtropical countries.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 750 · see citing works
Pathogenesis of Poliomyelitis Reappraisal in the Light of New Data
Sabin, A. B. (1956) · Science · doi:10.1126/science.123.3209.1151 · Cited by 236 · see citing works
Self-citationPresent Position of Immunization Against Poliomyelitis with Live Virus Vaccines
Sabin, A. B. (1959) · BMJ · doi:10.1136/bmj.1.5123.663 · Cited by 200 · see citing works
Self-citationPROPERTIES AND BEHAVIOR OF ORALLY ADMINISTERED ATTENUATED POLIOVIRUS VACCINE
Sabin, A. B. (1957) · JAMA · doi:10.1001/jama.1957.62980110008008 · Cited by 172 · see citing works
Self-citationSTUDIES ON VARIANTS OF POLIOMYELITIS VIRUS
Sabin, A. B., Hennessen, W., & Winsser, J. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.6.551 · Cited by 155 · see citing works
Self-citationTHE NATURAL HISTORY OF HUMAN POLIOMYELITIS
Sabin, A. B., & Ward, R. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.73.6.771 · Cited by 117 · see citing works
Self-citationPaul, J. R., Riordan, J. T., & Melnick, J. L. (1951) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119485 · Cited by 98 · see citing works
Sabin, A. B. (1955) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1955.tb42551.x · Cited by 91 · see citing works
Self-citationCultivation of Poliomyelitis Virus in Cultures of Human Foreskin and Embryonic Tissues.
Weller, T. H., Robbins, F. C., & Enders, J. F. (1949) · Experimental Biology and Medicine · doi:10.3181/00379727-72-17359 · Cited by 90 · see citing works
Paralytic Poliomyelitis: Old Dogmas and New Perspectives
Sabin, A. B. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.3.543 · Cited by 83 · see citing works
Self-citationCytopathogenic Effect of Poliomyelitis Viruses In vitro on Human Embryonic Tissues.
Robbins, F. C., Enders, J. F., & Weller, T. H. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-75-18202 · Cited by 81 · see citing works
The Control of Poliomyelitis in Brazil
Risi, J. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s400 · Cited by 76 · see citing works
BEHAVIOR OF CHIMPANZEE-AVIRULENT POLIOMYELITIS VIRUSES IN EXPERIMENTALLY INFECTED HUMAN VOLUNTEERS
Sabin, A. B. (1955) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195507000-00001 · Cited by 69 · see citing works
Self-citationHale, J. H., Doraisingham, M., Kanagaratnam, K., et al. (1959) · BMJ · doi:10.1136/bmj.1.5137.1541 · Cited by 69 · see citing works
Outside Europe. Is poliomyelitis a serious problem in developing countries?--the Danfa experience.
Nicholas, D. B., Kratzer, J. H., Ofosu-Amaah, S., et al. (1977) · BMJ · doi:10.1136/bmj.1.6067.1009 · Cited by 68 · see citing works
Cultivation of Poliomyelitis Virus in vitro in Human Embryonic Nervous Tissue
Sabin, A. B., & Olitsky, P. K. (1936) · Experimental Biology and Medicine · doi:10.3181/00379727-34-8619c · Cited by 67 · see citing works
Self-citationSome Observations on Poliomyelitis Lameness Surveys
Bernier, R. H. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s371 · Cited by 62 · see citing works
Elimination of Poliomyelitis in Finland
LAPINLEIMU, K. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s457 · Cited by 57 · see citing works
INTRAFAMILIAL AND INTERFAMILIAL SPREAD OF LIVING VACCINE STRAINS OF POLIOVIRUSES
Gelfand, H. M. (1959) · JAMA · doi:10.1001/jama.1959.03010170001001 · Cited by 54 · see citing works
Pathogens of Siphonaptera (fleas).
Castillo, J. M. (1980) · PubMed · Cited by 50 · see citing works
Community-Wide Use of Oral Poliovirus Vaccine
Sabin, A. B. (1961) · American journal of diseases of children · doi:10.1001/archpedi.1961.04020060004002 · Cited by 49 · see citing works
Self-citationSabin, A. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s391 · Cited by 48 · see citing works
Self-citationLaForce, F. M., Lichnevski, M. S., Keja, J., et al. (1980) · PubMed · Cited by 47 · see citing works
A CONCEPT OF THE MECHANISM OF IMMUNITY FOR PREVENTING PARALYSIS IN POLIOMYELITIS
SALK, J. E. (1955) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1955.tb42563.x · Cited by 46 · see citing works
Cuba: Mass Polio Vaccination Program, 1962–1982
Cruz, R. R. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s408 · Cited by 44 · see citing works
ATTENUATED TYPE 1 POLIOVIRUS VACCINE
Horstmann, D. M. (1959) · JAMA · doi:10.1001/jama.1959.03010010003001 · Cited by 43 · see citing works
Control of Paralytic Poliomyelitis in the United States
Schonberger, L. B., Kaplan, J., Kim-Farley, R. J., Moore, M., EDDINS, D. L., & Hatch, M. H. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s424 · Cited by 43 · see citing works
One-Dose Immunization Against Paralytic Poliomyelitis Using a Noninfectious Vaccine
SALK, J. E. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s444 · Cited by 42 · see citing works
STUDIES ON THE DEVELOPMENT OF NATURAL IMMUNITY TO POLIOMYELITIS IN LOUISIANA
Gelfand, H. M., LeBlanc, D. R., Potash, L., & Fox, J. P. (1959) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120080 · Cited by 37 · see citing works
IMMUNIZATION OF CHIMPANZEES AND HUMAN BEINGS WITH AVIRULENT STRAINS OF POLIOMYELITIS VIRUS
Sabin, A. B. (1955) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1955.tb42565.x · Cited by 36 · see citing works
Self-citationSabin, A. B. (1962) · Royal Society of Health Journal · doi:10.1177/146642406208200205 · Cited by 36 · see citing works
Self-citationACTIVE IMMUNITY TO POLIOMYELITIS IN CHIMPANZEES FOLLOWING SUBCLINICAL INFECTION
Melnick, J. L., & Horstmann, D. M. (1947) · The Journal of Experimental Medicine · doi:10.1084/jem.85.3.287 · Cited by 36 · see citing works
Control of Poliomyelitis: A Continuing Paradox
Horstmann, D. M. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.4.540 · Cited by 35 · see citing works
Sabin, A. B. (1954) · Science · doi:10.1126/science.120.3113.357 · Cited by 30 · see citing works
Self-citationPresent status of attenuated live virus poliomyelitis vaccine.
SABIN, A. B. (1957) · PubMed · Cited by 29 · see citing works
Self-citationControl of Poliomyelitis in Africa
Foster, S. O., Kesseng-Maben, G., N'jie, H., et al. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s433 · Cited by 29 · see citing works
SUBCLINICAL POLIOMYELITIS IN THE CHIMPANZEE AND ITS RELATION TO ALIMENTARY REINFECTION1
Howe, H. A., Bodian, D., & Morgan, I. M. (1950) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119379 · Cited by 28 · see citing works
International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine and the Soviets.
Benison, S. (1982) · PubMed · Cited by 27 · see citing works
Is poliomyelitis a serious problem in developing countries? - the Danfa experience.
Nicholas, D. B., Kratzer, J. H., Ofosu-Amaah, S., et al. (1977) · Cited by 27 · see citing works
Deeny, J., & MacCormack, J. D. (1946) · The Lancet · doi:10.1016/s0140-6736(46)90656-3 · Cited by 24 · see citing works
Modern approaches to vaccines : molecular and chemical basis of virus virulence and immunogenicity
Chanock, R. M., & Lerner, R. A. (1984) · Medical Entomology and Zoology · Cited by 23 · see citing works
STATUS OF FIELD TRIALS WITH AN ORALLY ADMINISTERED, LIVE ATTENUATED POLIOVIRUS VACCINE
Sabin, A. B. (1959) · JAMA · doi:10.1001/jama.1959.03010250001001 · Cited by 23 · see citing works
Self-citationTHE NATURAL HISTORY OF HUMAN POLIOMYELITIS
Sabin, A. B., & Ward, R. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.74.6.519 · Cited by 21 · see citing works
Self-citationHorstmann, D. M., & Melnick, J. L. (1950) · The Journal of Experimental Medicine · doi:10.1084/jem.91.6.573 · Cited by 21 · see citing works
Takatsu, T., TAGAYA, I., & Hirayama, M. (1973) · PubMed · Cited by 20 · see citing works
Eradication of Poliomyelitis in the United States: A Commentary on the Salk Reviews
Fox, J. P. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.2.277 · Cited by 20 · see citing works
PRESENT STATUS AND FUTURE POSSIBILITIES OF A VACCINE FOR THE CONTROL OF POLIOMYELITIS
Sabin, A. B. (1953) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1953.02050080311006 · Cited by 19 · see citing works
Self-citationLive Attenuated Oral Poliovirus Vaccine
Melnick, J. L. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s323 · Cited by 19 · see citing works
Immunity Induced by Inactivated Poliovirus Vaccine and Excretion of Virus
Chin, T. D. Y. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s369 · Cited by 18 · see citing works
Theiler, M. (1941) · Cited by 17 · see citing works
EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN
SUBCOMMITTEE, M. T. (1967) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.20.167 · Cited by 16 · see citing works
Inadequate serological surveys for immunity to poliomyelitis
Sabin, A. B. (1983) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1983.tb99352.x · Cited by 15 · see citing works
Self-citationSabin, A. B., & Silva, E. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113530 · Cited by 14 · see citing works
Self-citationPoliomyelitis Control in Japan
Shimojo, H. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s427 · Cited by 14 · see citing works
Sabin, A. B. (1984) · JAMA · doi:10.1001/jama.251.22.2988 · Cited by 12 · see citing works
Self-citationOral, Live Poliovirus Vaccine for Elimination of Poliomyelitis
Sabin, A. B. (1960) · Archives of Internal Medicine · doi:10.1001/archinte.1960.03820010007003 · Cited by 12 · see citing works
Self-citationImmunity in poliomyelitis, with special reference to vaccination.
SABIN, A. B. (1955) · PubMed · Cited by 12 · see citing works
Self-citationMass Vaccination Against Poliomyelitis in Mexico
de Castro, J. F. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s397 · Cited by 11 · see citing works
Two Voluntary Mass Immunization Programs Using Sabin Oral Vaccine
Johns, R. B. (1963) · JAMA · doi:10.1001/jama.1963.03700030047010 · Cited by 11 · see citing works
THE TRIAL USE OF SABIN'S ATTENUATED TYPE 1 POLIOVIRUS VACCINE IN A VILLAGE IN SOUTHERN ARIZONA1
Horstmann, D. M., Niederman, J., Riordan, J. T., et al. (1959) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120068 · Cited by 11 · see citing works
Long-Term Use of Oral Poliovirus Vaccine from Sabin Strains in the Soviet Union
Grachev, V. P. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s321 · Cited by 10 · see citing works
Vaccine control of poliomyelitis in the 1980s.
SABIN, A. B. (1983) · PubMed · Cited by 10 · see citing works
Self-citation[Prevention of poliomyelitis by vaccination].
Auricchio, L. (1958) · PubMed · Cited by 10 · see citing works
The elimination of poliomyelitis virus from the human mouth or nose.
Ward, R., & Walters, B. (1947) · PubMed · Cited by 9 · see citing works
Poliomyelitis Incidence in the Soviet Union in 1960
Sabin, A. B. (1961) · JAMA · doi:10.1001/jama.1961.63040160015013c · Cited by 9 · see citing works
Self-citationBijkerk, H., Draaisma, F. J., van der Gugten, A. C., et al. (2007) · JAMA · doi:10.1001/jama.298.15.1811 · Cited by 9 · see citing works
Active immunization against poliomyelitis with live attenuated viruses
Verlinde, J. D., Wilterdink, J. B., & Kret, A. (1959) · Archives of Virology · doi:10.1007/bf01242240 · Cited by 8 · see citing works
Approaches to the Development of New Poliovirus Vaccines Based on Molecular Genetics
Nomoto, A., Toyoda, H., Kataoka, Y., et al. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s494 · Cited by 7 · see citing works
EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN
SUBCOMMITTEE, E. (1967) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.20.303 · Cited by 6 · see citing works
EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN I. GENERAL PREFACE
Saito, K. (1966) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.19.269 · Cited by 6 · see citing works
Evolution of the Poliomyelitis Vaccination Program in Costa Rica
de Coto, E. M. L. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s442 · Cited by 4 · see citing works
On the trail of avirulent viruses for immunization against poliomyelitis.
SABIN, A. B. (1954) · PubMed · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703 · see citing works
Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202 · see citing works
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157 · see citing works
Inactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135 · see citing works
Svitkin, Y. V., Cammack, N., Minor, P. D., & Almond, J. W. (1990) · Virology · doi:10.1016/0042-6822(90)90190-3 · Cited by 116 · see citing works
Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion
Wells, A. I., & Coyne, C. B. (2019) · Viruses · doi:10.3390/v11050460 · Cited by 109 · see citing works
Molecular Mechanisms of Attenuation of the Sabin Strain of Poliovirus Type 3
Guest, S., Pilipenko, E., Sharma, K., Chumakov, K., & Roos, R. P. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11097-11107.2004 · Cited by 101 · see citing works
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97 · see citing works
Georgescu, M. M., Balanant, J., Macadam, A., Otelea, D., Combiescu, M., Combiescu, A. A., Crainic, R., & Delpeyroux, F. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7758-7768.1997 · Cited by 83 · see citing works
Korotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73 · see citing works
Mechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67 · see citing works
Agol, V. I., Pilipenko, E. V., & Slobodskaya, O. R. (1996) · Journal of Biotechnology · doi:10.1016/0168-1656(95)00088-7 · Cited by 27 · see citing works
Strategy for construction of live picornavirus vaccines
Nomoto, A., Iizuka, N., Kohara, M., & Arita, M. (1988) · Vaccine · doi:10.1016/s0264-410x(88)80015-x · Cited by 24 · see citing works
- Authors
- Sabin, A. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Sabin, A. B.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-03-01
- Volume
- 151
- Issue
- 3
- Pages
- 420-436
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2072115742
- Cited by
- 281
- References
- 72
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 13 · 2013: 8 · 2012: 14
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- oral polio vaccine, poliomyelitis elimination, vaccine strain selection, neurovirulence, vaccine history
- MeSH terms
- Animals, Haplorhini, Pan troglodytes, Clinical Trials as Topic, Genes, Viral, Humans, Immunization Schedule, Motor Neurons, Poliomyelitis, Poliovirus Vaccine, Oral, Tropical Climate, United States, Vaccination, Virulence, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review